MedTrace Logo

The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

NCT02623036 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-05-25

No results posted yet for this study

Summary

The purpose of this study is to use ambulatory blood pressure monitors to investigate whether enalapril is superior to lisinopril in managing nocturnal hypertension in patients with resistant hypertension currently treated with daytime angiotensin converting enzyme inhibitors.

Conditions

  • Hypertension, Resistant to Conventional Therapy

Interventions

DRUG

Equivalent dose enalapril

Chronotherapy with enalapril.

DRUG

Equivalent dose lisinopril

Chronotherapy with lisinopril

Sponsors & Collaborators

  • Memorial Health University Medical Center

    lead OTHER

Principal Investigators

  • John D. Bucheit, Pharm D · Memorial Health University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02623036 on ClinicalTrials.gov